liver transplantation

美 　英

• 網(wǎng)絡(luò)肝移植；肝臟移植；肝臟移植手術(shù)

例句

Preservation of the middle hepatic vein (MHV) for a right split liver transplantation (SLT) in an adult recipient is still controversial.

成人受體保留肝中靜脈的劈裂式右肝移植仍有爭議。

Liver transplantation is still the only choice to cure PSC so far.

目前認為肝移植仍是治愈PSC的惟一選擇。

Therefore, the treatment of affected children was not disease- specific and aimed at optimizing care to help reduce liver transplantation.

因此，對受累兒童的治療不是疾病特異性的而是旨在采用最佳的治療以助于避免肝臟移植。

Introduction: Orthotopic liver transplantation is considered to be one of the highest risk non-cardiac surgeries.

簡介：原位肝移植被視為最危險的非心臟外科手術(shù)之一。

Orthotopic liver transplantation is one of the most promising treatments for liver diseases in the terminal stage.

肝移植是終末期肝病最有希望的治療方法之一。

Liver transplantation offers the best chance for a cure in patients with small tumors and significant associated liver disease.

肝移植提供了一個小腫瘤和相關(guān)性肝病治愈的最佳機會。

Objective To investigate the long-term complications after liver transplantation.

目的探討肝移植患者術(shù)后遠期并發(fā)癥的發(fā)病情況。

Objective To discuss the long-term effect of orthotopic liver transplantation to patients with hepatic myelopathy.

目的探討肝移植對肝性脊髓病的遠期療效。

Some of these reported cases resulted in fatalities or liver transplantation.

這些已報告的事件中部分已導(dǎo)致死亡或肝移植。

Therefore, they should be considered potential candidates for orthotopic liver transplantation.

因此，他們應(yīng)該被選為是原為肝移植的潛在候選人。

Calcineurin inhibitors (CNIs) are the cornerstone of immunosuppression after liver transplantation.

鈣調(diào)磷酸酶抑制劑（CNIs）是肝移植術(shù)后免疫抑制的基石。

Objective To sum up the clinic experience of perioperative management of orthotopic liver transplantation.

目的總結(jié)原位肝移植圍手術(shù)期處理的臨床經(jīng)驗。

Stem cell therapy is expected to be the new technology for the replacement of liver transplantation.

干細胞治療成為有望替代肝移植的新技術(shù)。

Liver transplantation should not be advocated at the hospitals without primary working conditions.

沒有肝移植條件的醫(yī)院不提倡開展肝移植。

Objective To investigate the cause, prevention and treatment of severe pulmonary infection after liver transplantation.

目的探討肝移植術(shù)后發(fā)生重癥肺部感染的原因及其防治措施。

In the United States, geographic location also determines the likelihood of there being a quality liver transplantation center.

在美國，地理位置也對是否可能存在符合要求的肝移植中心起決定作用。

Methods In two cases of liver transplantation, recipient splenic arteries were anastomosed with donor hepatic arteries in end to end way.

方法在二例肝移植病人中，選用受體脾動脈與供體肝動脈端端吻合以重建肝動脈。

Conclusions: Orthotopic liver transplantation is an effective therapy for hepatic carcinoma .

結(jié)論：原位全肝移植是治療肝癌的有效方法之一。

complication after liver transplantation is high, the cause and clinical manifestation are multiplicity.

結(jié)論肝移植術(shù)后神經(jīng)精神并發(fā)癥的發(fā)生率較高，病因及臨床表現(xiàn)形式多樣。

Methods Analyze immunology marker and pathologic data of two auxiliary liver transplantation patients.

方法分析二例輔助性肝臟移植患者的免疫學(xué)指標(biāo)和病理學(xué)資料。

Conslusion Living donor liver transplantation is one of effect ways for the treatment of severe hepatitis.

結(jié)論活體肝移植術(shù)是治療重型肝炎的有效方法之一。

Conclusions Choledochoscope is effective in treatment of biliary obstruction after orthotopic liver transplantation.

結(jié)論膽道鏡治療是肝移植術(shù)后肝內(nèi)膽管阻塞的有效治療方法。

Methods One case of AIH with hepatocirrhosis was treated by orthotopic liver transplantation.

方法對1例AIH肝硬化患者行肝移植手術(shù)。

Methods The literatures of the recent years on influence of hepatic cirrhotic portal hypertension on liver transplantation were reviewed.

方法對近年來有關(guān)肝硬變門靜脈高壓及其合并癥對肝移植的影響的文獻進行系統(tǒng)分析。

Conclusion The therapeutic effects of orthotopic liver transplantation for treating giant cavernous haemangioma of liver were satisfactory.

結(jié)論原位肝移植治療肝臟巨大海綿狀血管瘤療效令人鼓舞。

Conclusion Early enteral nutrition and right used in patients with liver transplantation are safe and effective.

結(jié)論肝移植術(shù)后早期應(yīng)用腸內(nèi)營養(yǎng)和重組人生長激素是安全有效的。

Complicated and multi-systematic physiopathologic changes may occur during the perioperative period of the liver transplantation.

肝移植術(shù)期間病人可發(fā)生多系統(tǒng)復(fù)雜的劇烈的病理生理改變。

Conclusions Biliary injury is an important reason for biliary complications after liver transplantation.

結(jié)論膽道保存性損傷是引起肝移植術(shù)后膽道并發(fā)癥的重要原因。

In some cases, the left lateral living liver transplantation might be contraindicated .

少數(shù)情況下肝左外葉活體移植為禁忌證。

PCH offers a feasible option for liver transplantation in those patients with complex thrombosis of the mesenteric and portal circulation.

PCH是肝移植后腸系膜和門經(jīng)脈循環(huán)中出現(xiàn)符合血栓后的可行性治療選擇。

Hepatology Digest: There is now no effective treatment for Wilson's disease related liver cirrhosis besides liver transplantation.

國際肝病：除了肝移植外，目前還沒有有效治療Wilson病相關(guān)肝硬化的方法。

Objective: To investigate the significance of the change of blood glucose during orthotopic liver transplantation.

目的：探討血糖的動態(tài)變化在原位肝移植術(shù)中的臨床意義。

Conclusions The model could be used as an ideal model in studying cytologic and immunologic events in bile after liver transplantation.

結(jié)論該模型是研究肝移植術(shù)后膽汁成分、膽汁細胞學(xué)、免疫學(xué)指標(biāo)變化的理想模型。

BACKGROUND: Liver transplantation (LT) represents a curative treatment for small hepatocellular carcinoma (HCC).

背景：肝移植是小肝細胞癌的根治療法。

Objective To evaluate the clinical value and prognostic factors of orthotopic liver transplantation for hepatocellular carcinoma.

目的探討肝移植治療肝細胞型肝癌的臨床價值及影響預(yù)后的因素。

Objective To summarize the application and advancement of liver transplantation for hepatic metastasis from neuroendocrine tumor.

目的介紹肝移植治療神經(jīng)內(nèi)分泌腫瘤肝轉(zhuǎn)移的進展。

The authors reported their observation and nursing of complications by indwelling floating catheter in post liver-transplantation patients.

筆者報道了肝移植患者留置漂浮導(dǎo)管并發(fā)癥的觀察及護理。

Objective: To explore the prophylaxis and treatment strategies for psychic syndrome in patients after piggyback liver transplantation.

目的：探討背馱式肝移植患者術(shù)后神經(jīng)精神并發(fā)癥的防治對策。

Objective To summarize our experience in performing modified hepatic outflow tract reconstruction in liver transplantation.

目的總結(jié)我院肝移植時應(yīng)用改良的肝臟流出道重建方式的經(jīng)驗。

Objective To investigate the prevention of gram-positive cocci infection by oral administration of vancomycin after liver transplantation.

目的研究口服萬古霉素對肝移植術(shù)后革蘭氏陽性球菌感染的預(yù)防作用。